MEA Anti Fungal Agents Market

ID: MRFR/Pharma/1942-HCR
84 Pages
Satyendra Maurya
Last Updated: June 26, 2026
Anti-Fungal Agents Market Research Report Information, by Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis and Others), Drug Class (Azoles, Pyrimidines, Echinocandins, Polyenes, Allylamines and Others) and Route of Administration (Oral, Local and Others) - Growth & Industry Forecast 2025 To 2035
MEA Anti Fungal Agents Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.17%
2024 Market Size$ 20.5 Billion
2032 Market Size$ 6.88 Billion
2035 Market Size$ 35.7 Billion
Key Players
Apple Inc
Microsoft Corp
Amazon.com Inc
Alphabet Inc
Berkshire Hathaway Inc
Tesla Inc
Opportunities
  • Market Growth Projections
  • Growing Awareness and Education
  • Advancements in Antifungal Research
  1. 1 Introduction
    1. 1.1 Definition
    2. 1.2 Scope of Study
    3. 1.3 Research Objective
    4. 1.4 Assumptions & Limitations
    5. 1.5 Market Structure:
  2. 2 Research Methodology
    1. 2.1 Research Process
    2. 2.2 Primary Research
    3. 2.3 Secondary Research
  3. 3 Market Dynamics
    1. 3.1 Drivers
    2. 3.2 Restraints
    3. 3.3 Opportunities
    4. 3.4 Challenges
    5. 3.5 Macroeconomic Indicators
  4. 4 Market Factor Analysis
    1. 4.1 Porter’s five forces model
      1. 4.1.1 Bargaining Power of suppliers
      2. 4.1.2 Bargaining Power of Customer
      3. 4.1.3 Intensity of Competitor’s
      4. 4.1.4 Threat of New Entrants
  5. 5 MEA Anti Fungal Agents Market, by Therapeutic Indication
    1. 5.1 Introduction
      1. 5.1.1 Aspergillosis
      2. 5.1.2 Dermatophytosis
      3. 5.1.3 Candidiasis
      4. 5.1.4 Others
  6. 6 MEA Anti Fungal Agents Market, by Drug Class
    1. 6.1 Introduction
      1. 6.1.1 Azoles
      2. 6.1.2 Pyrimidines
      3. 6.1.3 Echinocandins
      4. 6.1.4 Polyenes
      5. 6.1.5 Allylamines
      6. 6.1.6 Others
  7. 7 MEA Anti Fungal Agents Market, by Route of Administration
    1. 7.1 Introduction
      1. 7.1.1 Oral
      2. 7.1.3 Local
      3. 7.1.4 Others
  8. 8 Middle MEA Anti Fungal Agents Market, by Country
    1. 8.1 Introduction
    2. 8.2 UAE
    3. 8.3 Egypt
    4. 8.4 Saudi Arabia
    5. 8.5 Kuwait
    6. 8.6 Qatar
    7. 8.7 Oman
  9. 9 Company Landscape
    1. 9.1 Introduction
      1. 9.1.1 Mergers Acquisitions
      2. 9.1.2 Collaborations
      3. 9.1.3 Release/New Product Launches
      4. 9.1.4 Other (Expansion, Updates, Partnership)
  10. 10 Company Profile
    1. 10.1 Novartis AG
      1. 10.1.1 Company Overview
      2. 10.1.2 Product/Business Segment Overview
      3. 10.1.3 Financials
      4. 10.1.4 Key Developments
      5. 10.1.5 SWOT Analysis
    2. 10.2 Pfizer, Inc.
      1. 10.2.1 Overview
      2. 10.2.2 Product/Business Segment Overview
      3. 10.2.3 Financials
      4. 10.2.4 Key Developments
      5. 10.2.5 SWOT Analysis
    3. 10.3 Sanofi-Aventis
      1. 10.3.1 Overview
      2. 10.3.2 Product/Business Segment Overview
      3. 10.3.3 Financials
      4. 10.3.4 Key Developments
      5. 10.3.5 SWOT Analysis
    4. 10.4 Merck & Co.
      1. 10.4.1 Overview
      2. 10.4.2 Product/Business Segment Overview
      3. 10.4.3 Financials
      4. 10.4.4 Key Developments
      5. 10.4.5 SWOT Analysis
    5. 10.5 Enzon Pharmaceuticals
      1. 10.5.1 Overview
      2. 10.5.2 Product/Business Segment Overview
      3. 10.5.3 Financials
      4. 10.5.4 Key Developments
      5. 10.5.5 SWOT Analysis
    6. 10.6 Bayer AG
      1. 10.6.1 Overview
      2. 10.6.2 Product/Business Segment Overview
      3. 10.6.3 Financials
      4. 10.6.4 Key Developments
      5. 10.6.5 SWOT Analysis
    7. 10.7 Astellas Pharma
      1. 10.7.1 Overview
      2. 10.7.2 Product/Business Segment Overview
      3. 10.7.3 Financials
      4. 10.7.4 Key Developments
      5. 10.7.5 SWOT Analysis
    8. 10.7 GlaxoSmithKline plc
      1. 10.7.1 Overview
      2. 10.7.2 Product/Business Segment Overview
      3. 10.7.3 Financials
      4. 10.7.4 Key Developments
      5. 10.7.5 SWOT Analysis
    9. 10.7 Abbott
      1. 10.7.1 Overview
      2. 10.7.2 Product/Business Segment Overview
      3. 10.7.3 Financials
      4. 10.7.4 Key Developments
      5. 10.7.5 SWOT Analysis
    10. 10.7 Sigma-Aldrich
      1. 10.7.1 Overview
      2. 10.7.2 Product/Business Segment Overview
      3. 10.7.3 Financials
      4. 10.7.4 Key Developments
      5. 10.7.5 SWOT Analysis
    11. 10.8 Others
  11. 11 Appendix
    1. List of Tables
  12. TABLE 1 MIDDLE EAST AND AFRICA ANTI-FUNGAL AGENTS MARKET, 2023-2030 (USD MILLION)
  13. MEA Anti Fungal Agents Market, BY THERAPEUTIC INDICATION,2023-2030 (USD MILLION)
  14. TABLE 3 MIDDLE EAST AND AFRICA MEA Anti Fungal Agents Market, BY DRUG CLASS, 2023-2030 (USD MILLION)
  15. TABLE 4 MIDDLE MEA Anti Fungal Agents Market, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  16. MEA Anti Fungal Agents Market, BY REGION, 2023-2030 (USD MILLION)
    1. List of Figures
  17. FIGURE 1 RESEARCH PROCESS
  18. FIGURE 2 PORTERS FIVE FORCES MODEL
  19. FIGURE 3 MIDDLE EAST AND AFRICA ANTI-FUNGAL MEA Anti Fungal Agents Market, BY THERAPEUTIC INDICATION
  20. FIGURE 4 MIDDLE EAST AND AFRICA ANTI-FUNGAL MEA Anti Fungal Agents Market, BY DRUG CLASS
  21. FIGURE 5 MIDDLE EAST AND AFRICA ANTI-FUNGAL AGENTS MEA Anti Fungal Agents Market, BY ROUTE OF ADMINISTRATION
  22. FIGURE 6 MIDDLE EAST AND AFRICA ANTI-FUNGAL MEA Anti Fungal Agents Market, BY REGION
  23. FIGURE 7 MIDDLE EAST AND AFRICA ANTI-FUNGAL AGENTS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

Anti-Fungal Agents Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.